Published: 10 November 2023
Author(s): Nikolaos K. Gatselis, Aggeliki Lyberopoulou, Vasiliki Lygoura, George Giannoulis, Anna Samakidou, Antonia Vaiou, Katerina Antoniou, Katerina Triantafyllou, Aggelos Stefos, Sarah Georgiadou, Dimitrios Sagris, Dafni Sveroni, Stella Gabeta, George Ntaios, Gary L. Norman, George N. Dalekos
Issue: May 2024
Section: Original article

Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is characterized by a broad spectrum of clinical manifestations [1]. SARS-CoV-2 primarily targets the respiratory tract and can lead to severe respiratory illness, pneumonia, acute respiratory distress syndrome (ARDS), and other complications. However, COVID-19 is also a systemic disease and can cause various extrapulmonary complications. The severity of the disease ranges from asymptomatic or mild to a life-threatening illness with multi-organ failure leading to intensive care unit admission, intubation, or death [2–4].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.